Displaying 1 to 2 of 2 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
InterMune Inc Biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. |
United States | 24 Aug 2014 | Acquisition USD 8,300,000,000 (USD 8,300,000,000) deal size. Initial investment. Led the investment round. Active |
|
|
Santaris Pharma A/S |
Denmark | 4 Aug 2014 | Acquisition USD 450,000,000 (USD 450,000,000) deal size. Initial investment. Led the investment round. Active |